Comprehensive Cell Solutions (CCS)

https://www.comprehensivecellsolutions.com/contact/ Comprehensive Cell Solutions (CCS), is a business division of the New York Blood Center Enterprises, created to meet the needs of academic institutions, hospitals, biotech, pharmaceutical and startups organizations to launch new products, services, and perform clinical trials. CCS makes clinical and research challenges simple by leveraging NYBCes world-class expertise and experience in clinical trials management, regulatory and accreditation history. To date, CCS has: Collaborated with early stage companies to co-develop innovative products. Collaborated with diverse business entities and academic institutions to manage clinical trials, assist with budget, contracts, IRB submission, FDA submission, and invoicing. Initiated and participated in...

Clinical apheresis,cellular therapy ,tissue banking,regenerative medicine,immunotherapy,blood,clinical trials,genomics,research,fda approval,car-t,blood products,storage,and manufacturing

Comprehensive cell solutions (ccs) operates in the Biotechnology research industry.

Comprehensive cell solutions (ccs)'s revenue is 11m - 100m

Comprehensive cell solutions (ccs) has 11 - 50 employees.